Medicine & Advisory
@medicineadvisory • Joined January 17, 2022
At a glance
Subscribers
Last 29 days2.42K
Views
Last 29 days75.7K
Videos
Last 29 days84
Charts
Subscribers, views & videos over time
Subscribers gained (weekly) · 6 mo
Views gained (weekly) · 6 mo
Subs milestone changes (up to 30)
Views milestone changes (up to 30)
Engagement
Avg. views per video
902
Total views ÷ total videos
Views per subscriber
31×
Total views ÷ subscribers
Subs per video
29
Subscribers ÷ total videos
Revenue estimate
Details →Total (all-time): $53 – $152
Daily avg.: $0 – $0
Weekly avg.: $0 – $0
Last 29 days: $0 – $1
Based on estimated $0.7–$2 CPM.
Analytics tables
Analytics Table:Medicine & Advisory
| Date | subscribers | views | videos |
|---|---|---|---|
Jun 1, 2026 Jun 1 Mon | 2.42K +10 | 75.7K +76 | 84 -- |
May 25, 2026 May 25 Mon | 2.41K -- | 75.7K +99 | 84 -- |
May 18, 2026 May 18 Mon | 2.41K -- | 75.6K +154 | 84 -- |
May 11, 2026 May 11 Mon | 2.41K -- | 75.4K +240 | 84 +1 |
May 7, 2026 May 7 Thu | 2.41K -100 | 75.2K +7.40K | 83 +6 |
Apr 17, 2026 Apr 17 Fri | 2.51K -- | 67.8K -- | 77 -- |
Subscribers gained (weekly)
| Week | Subscribers gained | Change vs prev |
|---|---|---|
Apr 17, 2026 | -121 | -- |
May 7, 2026 | -101 | +20 |
May 11, 2026 | 0 | +100 |
May 18, 2026 | 0 | -- |
May 25, 2026 | 0 | -- |
Jun 1, 2026 | 10 | +10 |
Views gained (weekly)
| Week | Views gained | Change vs prev |
|---|---|---|
Apr 17, 2026 | 6 | -- |
May 7, 2026 | 7.40K | +7.40K |
May 11, 2026 | 240 | -7.16K |
May 18, 2026 | 154 | -86 |
May 25, 2026 | 99 | -55 |
Jun 1, 2026 | 76 | -23 |
About
Hii friends welcome to Medicine & Advisory YouTube channel. Medicines are used for treatment to relief from disease. But every Medicine has some role of administration. Medicines should in right amount in right time for right person. Here I shall try to provide about the Medicinal use,rout,dose and side effects. I sha…
- Handle
- @medicineadvisory
- Joined
- January 17, 2022
More features coming
We're working on new analytics and tools. Stay tuned.
More features coming
We're working on new analytics and tools. Stay tuned.